Soleus Capital Management, L.P. Pharvaris N.V. Transaction History
Soleus Capital Management, L.P.
- $1.44 Billion
- Q4 2024
A detailed history of Soleus Capital Management, L.P. transactions in Pharvaris N.V. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 814,652 shares of PHVS stock, worth $12.2 Million. This represents 1.09% of its overall portfolio holdings.
Number of Shares
814,652
Previous 598,169
36.19%
Holding current value
$12.2 Million
Previous $11.1 Million
40.96%
% of portfolio
1.09%
Previous 0.94%
Shares
9 transactions
Others Institutions Holding PHVS
# of Institutions
53Shares Held
39.1MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$113 Million5.17% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.4MShares$65.9 Million77.49% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$64.3 Million67.66% of portfolio
-
Viking Global Investors LP3.65MShares$54.8 Million0.24% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$49.5 Million17.1% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $506M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...